{"disease":{"id":"hypopigmentation","name":"hypopigmentation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06491615","title":"National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT06908889","title":"Characterization of Bacterial and Mycosis Skin Flora in Seborrheic Macular Hypopigmentation - Microbiome","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT04971200","title":"Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Premier Specialists, Australia","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}